Results 101 to 110 of about 507,096 (126)

Maximizing impact: the power of early HPV vaccination for long-term protection-lessons from a systematic review and meta-regression analysis. [PDF]

J Public Health (Oxf)
Navarro-Torné A, Aris E, Callegaro A, Benninghoff B, Yun H, Vetter V.   +5 more
europepmc   +1 more source

Trends in HPV vaccination among adults aged 27-45 years in the United States. [PDF]

Hum Vaccin Immunother
Fisher-Borne M, Done N, Eiden A, Mohanty S, Wang T, Zhu A, Sears E, Patterson-Lomba O, Song Y, Thompson EL.   +9 more
europepmc   +1 more source

Post-approval safety studies of vaccines in pregnancy: available regulatory guidance and next steps towards the more efficient generation of safety evidence. [PDF]

Front Drug Saf Regul
MacDonald SC, Guignard AP, Munoz FM, Dareng EO, Davis KJ, Machado MAA, Shmuel S, Taddei L, Marcelon L.   +8 more
europepmc   +1 more source

HPV Vaccines - An Overview. [PDF]

Indian J Dermatol
Ghosh A, Chatterjee S, Dawn A, Das A.
europepmc   +1 more source

Towards Global HPV Eradication: Single-Dose HPV Vaccination vs. Pseudoscience. [PDF]

Pathophysiology
Shiro R, Tsunoda I.
europepmc   +1 more source

New HPV Vaccines on the Market and Future Trends: A State-of-the-Art Review. [PDF]

Vaccines (Basel)
Akgör U, Temiz BE, Cengiz M, Ege HV, Joura E, Gültekin M.   +5 more
europepmc   +1 more source

Virus Biomimetic-Delivery Systems for the Production of Vaccines. [PDF]

Biomimetics (Basel)
Barbinta-Patrascu ME, Negut I, Bita B.
europepmc   +1 more source

Human Papillomavirus Vaccine immune responses in an Olive baboon model is not compromised by chronic <i>Schistosoma mansoni</i> infections. [PDF]

AIMS Microbiol
Obiero L, Songoro E, Omondi M, Nyakundi R, Ochola L.   +4 more
europepmc   +1 more source

Immunogenicity of an <i>Escherichia coli</i>-Produced Recombinant 9-Valent Human Papillomavirus Vaccine in Mice and Rats. [PDF]

Vaccines (Basel)
Liu YY, Yin F, Li WJ, Chen D, Wu SM, Chen X, Wang Y, Yang ZM, Zhang HJ, Liu YJ.   +9 more
europepmc   +1 more source